Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.
D000380:Agranulocytosis / Q000150:complications*; D000666:Amphotericin B / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D017053:Infection Control; D007422:Intestines / Q000382:microbiology*; D009268:Nalidixic Acid / Q000008:administration & dosage; D009355:Neomycin / Q000008:administration & dosage; D009503:Neutropenia / Q000150:complications*; D010356:Patient Isolation; D011112:Polymyxin B / Q000008:administration & dosage; D012867:Skin / Q000382:microbiology; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004338:Drug Combinations; D009268:Nalidixic Acid; D000666:Amphotericin B; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D009355:Neomycin; D011112:Polymyxin B; D013420:Sulfamethoxazole